TY  - JOUR
T1  - IOm report lays out a blueprint for improving regulatory systems worldwide
AU  - Mitka M
Y1  - 2012/05/16
N1  - 10.1001/jama.2012.4485
JO  - JAMA
SP  - 2014
EP  - 2016
VL  - 307
IS  - 19
N2  - 
In the United States, the supply chain issue has drawn the attention of Congress and the Food and Drug Administration (FDA) because an estimated 80% of active pharmaceutical ingredients and 40% of finished drugs come from abroad. Food is also a concern, as it is also increasingly imported; for example, about 85% of seafood consumed in the United States is from abroad.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.4485
UR  - http://dx.doi.org/10.1001/jama.2012.4485
ER  -